EBITDA

Perceptyx launches Develop, an AI system that measures learning comprehension in real time, aiming to prove training effectiveness and bridge a costly gap.

Peopoly's new FGF printer slashes costs by up to 90%, making massive, industrial-scale 3D printing accessible to businesses of all sizes.

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

Neighbourly Pharmacy earns its sixth 'Best Managed' award. We dive into the strategy behind its rapid growth and its promise to keep healthcare local.

Qualys's TotalCloud achieves the government's top security clearance, enabling federal agencies to accelerate secure cloud adoption and combat threats.

Global wealth manager AlTi Global is partnering with AI platform Nevis to automate workflows, empowering its advisors to focus on high-touch client service.

Industry titans from Manchester United to DraftKings will convene to map out the future of streaming, gaming, and sports in a shifting regulatory landscape.

OrganOx names Terumo's Naoya Iwata as new CEO, signaling a major push to expand its life-saving organ transplant technology across the globe.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

Marketeam.ai is solving modern AI's biggest reliability problem by leveraging Elixir and the BEAM, a battle-tested system designed for fault tolerance.

As AI risks mount, a new alliance between AIQA Global and SecureSky signals a market shift toward integrated governance and security to meet regulatory demands.

The global consulting firm is deploying a new AI platform to simplify benefits for employees while giving employers powerful data-driven strategic insights.

EOT launches ChronX, an AI system that empowers engineers to predict unknown equipment failures before they cost industries billions in unplanned downtime.

Former Meta exec Bar Clara Mendez McConnon is launching a new firm to bridge global capital with Israeli innovation, reversing a long-standing investment flow.

Anduril's new partnership with BlueTIDE 2026 offers startups a direct path to integrate their tech into the Lattice AI platform, bypassing old hurdles.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

After a major turnaround, the AI transport tech firm posts strong results, wins key U.S. contracts, and signals an aggressive acquisition strategy.

As AI's power demands strain global grids, PowerX's new battery system aims to turn data centers from consumers into revenue-generating grid partners.

The industrial giant unveils a new era of efficiency with advanced AI, a mobile factory, and the 'Suyuan' humanoid robot at Hannover Messe 2026.

Amid industry-wide price pressure, MariMed reports revenue growth and improved profitability, bolstered by savvy debt restructuring and brand expansion.